Shuangyan Cao

机构：Shihezi University, Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University · ORCID：0000-0001-5500-9641

发表论文 69 篇 · 总被引 1044 次 · h-index 18

代表论文

• TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis (2020 · Arthritis Research & Therapy · 被引 60)
• Identification of the urine and serum metabolomics signature of gout (2020 · Lara D. Veeken · 被引 42)
• Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy (2021 · Frontiers in Immunology · 被引 41)
• Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study (2021 · Clinical Rheumatology · 被引 21)
• Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China (2020 · Frontiers in Public Health · 被引 12)
• Efficacy and safety of Fengshi Gutong Capsule in patients with active ankylosing spondylitis: A 4-week randomized controlled, double-blinded, double-dummy trial (2021 · Journal of Ethnopharmacology · 被引 11)